Quantcast

Latest Clinical research Stories

2014-06-01 08:20:11

-Study appears in June 1 online edition- NORTHBROOK, Ill. and SAN FRANCISCO, JUNE 1, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN) today announced the online publication in the New England Journal of Medicine of the results from the Phase 3 PREVAIL trial, an international, randomized, double-blind, placebo-controlled clinical study of enzalutamide. The study evaluated the benefit...

2014-05-30 23:05:16

Patient-centered sessions to address challenges in recruitment and guidance for engagement Washington (PRWEB) May 30, 2014 Sessions at the DIA 2014 50th Annual Meeting will bring together patient advocates and those dedicated to finding much-needed therapies to discuss the role of patients in accelerating collaboration and challenges in recruitment in the medical products industry. The annual meeting will be held at the San Diego Convention Center from June 15 to 19. “Patient advocate...

2014-05-30 12:26:11

Expects to Imminently Receive Final Approval on 50 mg Strength; Has Received Tentative Approval on All Strengths PITTSBURGH, May 30, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today commented on the decision by the United States District Court for the Northern District of West Virginia denying Mylan's request for an injunction in its suit against the U.S. Food and Drug Administration (FDA), challenging the agency's decision regarding generic drug marketing exclusivity on Celecoxib...

2014-05-30 12:26:06

BETHESDA, Md., May 30, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) confirmed today the participation of five international experts for its upcoming 2014 PDA/FDA Virus and TSE Safety Conference, June 12-13, 2014, at the Hyatt Regency Hotel, Bethesda, Maryland. http://photos.prnewswire.com/prnvar/20130226/DC66667LOGO The five experts represent various countries, governmental and nongovernmental institutions, and will bring a wealth of knowledge and experience on the...

2014-05-29 23:15:34

While the FDA requires that sponsors and clinical investigators register all applicable clinical trials and report the results of these trials on the ClinicalTrials.gov website, are they submitting everything necessary and complying with the required timelines? Mark the calendar for Monday, June 9, when Scott Cunningham, a partner at Covington & Burling, conducts a webinar that focuses on the new reality of US and EU reporting. Falls Church, VA (PRWEB) May 29, 2014 Registering...

2014-05-29 23:13:33

Sophie McCallum, Director of Operations at Clinovo, Will Speak on June 3rd at the 2014 Partnerships in Medical Device Trials Conference in Chicago, IL. Sunnyvale, CA. (PRWEB) May 29, 2014 Sophie McCallum, Director of Operations at Clinovo, has been invited to discuss outsourcing strategies for clinical trials with Stryker Orthopedics, Aesculap, and Valeritas, at the 2014 Partnerships in Medical Device Trials Conference in Chicago, IL. Clinovo will also showcase at booth #7 ClinCapture...

2014-05-29 12:29:19

PRINCETON, N.J., May 29, 2014 /PRNewswire/ -- inVentiv Health Clinical, a leading global clinical research organization (CRO), and Advaxis, Inc. (NASDAQ: ADXS), a biotechnology company developing cancer immunotherapies, announced today that they have entered into a global master services agreement for the clinical development of certain immunotherapy product candidates in Advaxis's proprietary pipeline. inVentiv initially will work with Advaxis to develop clinical study protocols and will...

2014-05-29 10:28:27

University of Pennsylvania School of Medicine Guidelines based on retrospective case studies, case reports don't stand the test of time Clinical practice guideline recommendations related to screening and treatment can change markedly over time as new evidence about best practices and clinical outcomes of various treatments emerges. In a first-of-its-kind study, Penn Medicine researchers examined high-level recommendations published by the American College of Cardiology (ACC) and the...

2014-05-29 08:29:36

REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 3rd. Presentation details are as follows: Jefferies Global Healthcare ConferenceDate: June 3, 2014Location: Grand Hyatt New YorkPresentation Time: 1:30...

2014-05-29 08:29:27

SYDNEY, May 29, 2014 /PRNewswire/ -- RNAi-based therapeutics company, Benitec Biopharma Limited (ASX: BLT) is pleased to announce that it has dosed the first patient in its 'first in man', Phase I/IIa clinical trial for TT-034, a ddRNAi-based therapeutic, designed to treat and potentially cure hepatitis C (HCV) with a single injection. Benitec Biopharma's CEO and Managing Director, Peter French said, "The commencement of this clinical trial of TT-034 represents a landmark in the Company's...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.